Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest-specific protein 1 is a 345-amino acid cell membrane-associated protein that blocks cell cycle progression (prevents entry into S phase) and induces apoptosis, acting as a putative tumor suppressor. GAS1 modulates the activity of the RET receptor in a ligand-independent manner and acts in the Hedgehog signaling pathway as a co-receptor, regulating organ development and maintaining cellular quiescence. It is highly expressed in the central nervous system and some peripheral tissues, and loss of function is linked to increased cell proliferation in tumors and developmental abnormalities such as kidney hypoplasia. GAS1's tumor suppressor activity is thought to contribute to decreased progression and metastasis in certain cancers, while its developmental roles are critical in the CNS and kidney.
not applicable; GAS1 exerts tumor-suppressive, apoptotic, and cell cycle effects through endogenous expression and regulation rather than drug interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest-specific protein 1 (GAS1).